Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Lenvatinib plus Pembrolizumab plus Chemotherapy for the Treatment of Advanced/Metastatic Gastroesophageal Adenocarcinoma
Phase: 3Phase III in Spain, 2Phase II, 1Phase I